News

February 21, 2018

Phase 2 Clinical Trial Results for CK-2127107 Expected in Second Quarter of 2018

Phase 2 Clinical Trial Results for CK-2127107 Expected in Second Quarter of 2018

Cytokinetics is currently conducting a Phase 2 clinical trial of CK-2127107 – now referred to by the generic name, reldesemtiv – which is designed to assess the investigational agent’s effect on multiple measures of muscle function in both ambulatory and non-ambulatory...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

February 14, 2018

Biogen Releases Statement on CHERISH Data and Plans for New Clinical Research

Biogen Releases Statement on CHERISH Data and Plans for New Clinical Research

Biogen has provided the following community statement on the final results from CHERISH, a Phase 3 study of SPINRAZA. 

Dear Members of the SMA community,

This past December marked one year since the FDA approval of SPINRAZA® (nusinersen), the first and only treatment...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

February 9, 2018

Winter 2018 Compass Now Available Online

Winter 2018 Compass Now Available Online

The winter 2018 issue of Compass is now available online.

This issue covers Cure SMA’s community survey, and reviews how data is used to improve research, care and coverage in the SMA...

READ MORE   |  

Topics: Support & Care, Research, Front Page News

Items 1 - 3 of 180  12345678910Next

© 2018 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software